2014 at a groundbreaking ceremony in Summit, N.J., for Celgene, the pharmaceutical company he led until stepping down to run for United States Senate. To his right are Representative Leonard Lance of New Jersey and former Gov. Chris Christie. Mel Evans/Associated Press"},"identifier":"100000006098011 Sba8b80411187", "imageIdentifier":"el26e7bde26613f 50£2609cb8776d827", "layout": "fullbleed- image", "role":"photo", "type": "scalable image"}, {"identifier":" anf-caption-— 1","inlineTextStyles": [{"range":{"length":27, "start ":261},"textStyle":"photo- credit"}],"layout":"default-caption", "role": "caption", "text":"Bob Hugin spoke in 2014 at a groundbreaking ceremony in Summit, N.J., for Celgene, the pharmaceutical company he led until stepping down to run for United States Senate. To his right are Representative Leonard Lance of New Jersey and former Gov. Chris Christie. Mel Evans/Associated Press ","type™:"text"}],"identifier":" anf-container- 5","layout"™:"image- container", "role":"container", "type":"container"}],"identifier":" anf-section- 2","layout": "default- section", "role":"section", "scene": {"fadeColor":"#FFFFFF","type":"fading sticky header"} ,"type"™:"section"}, {"additions": [{"URL":"https://www.businesswire.com/news/home/2018012 9005762/en/Celgene-Announces-Retirement-Executive-Chairman-Bob- Hugin", "range": {"length":34,"start":194},"type"™:"link"}],"identifier":" anf-body- 6", "inlineTextStyles":[{"range": {"length":363,"start":0},"textsStyle":" anf-ts- i"},{"range™: {"length":363,"start":0},"textStyle":" anf-ts-1"}],"layout":"default- body", "role":"body", "text":"When Bob Hugin joined Celgene in 1999 as its chief financial officer, the company was a struggling biotech that sold just one product ae" a leprosy drug 4€" and faced a shaky future. By the time he stepped down as executive chairman in February to run for United States Senate, Celgene had become a pharmaceutical powerhouse with a market value of nearly $80 billion.","type":"text"}, {"ad